1,161 results on '"concurrent chemotherapy"'
Search Results
752. Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell carcinoma: a phase 2 single-institution study
753. Ifosfamide and epirubicin combination in untreated sarcomas: two treatment schedules
754. Salivary Gland Tumors Treated with Adjuvant Intensity Modulated Radiation with or without Concurrent Chemotherapy: A Recent Experience
755. Re-irradiation Combined with Concurrent Chemotherapy for Patients with Locally Recurrent Nasopharyngeal Carcinoma: Clinical Advantage of Intensity Modulated Radiotherapy using Helical Tomotherapy
756. Low-dose Fractionated Radiotherapy (LD-FRT) and Concurrent Chemotherapy (CT) in Glioblastoma Multiforme (GBM): Interim Analysis of a Clinical Trial
757. Concurrent chemotherapy and radiation for locally advanced squamous cell cancers: what is the schedule of choice?
758. Concurrent chemotherapy and radiation therapy in primary cancer of the cervix
759. Conformal Radiotherapy Facilitates the Delivery of Concurrent Chemotherapy and Radiotherapy: A Case of Primitive Neuroectodermal Tumour of the Chest Wall
760. Patterns of First Failure in a Phase II Study of Accelerated High Dose Thoracic Radiation Therapy (TRT) with Concurrent Chemotherapy for Limited Small-cell Lung Cancer (LSCLC): Radiation Therapy Oncology Group (RTOG) 0239
761. Concurrent Chemotherapy and Proton Beam Therapy for Esophageal Cancer
762. P1040 High dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes
763. 139 CONCURRENT CHEMOTHERAPY (CHT) AND INTENSITY MODULATED RADIATION THERAPY (IMRT) VERSUS IMRT ALONE FOR THE TREATMENT (TT) OF STAGE (STG) III–IV OROPHARYNGEAL CARCINOMA (OPC): A RETROSPECTIVE STUDY AT THE NOVA SCOTIA CANCER CENTRE (NSCC)
764. Characteristics Associated With Swallowing Changes After Concurrent Chemotherapy and Radiotherapy in Patients With Head and Neck Cancer
765. Advances in cervical cancer management from North American cooperative group clinical trials.
766. Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer
767. Impact of Treatment Duration and Delays on In-field Disease Control for Twice-daily Radiotherapy (BID-RT) with Concurrent Chemotherapy in Limited-stage Small-cell Lung Cancer (SCLC)
768. MO-D-AUD A-02: A Clinician's View of QUANTEC
769. A Randomized Study of Involved-Field Irradiation Versus Elective Nodal Irradiation in Combination With Concurrent Chemotherapy for Inoperable Stage III Nonsmall Cell Lung Cancer
770. Can Bone Marrow Dosimetric Parameters Predict for Myelotoxicity in Cervical Cancer Patients Treated With Concurrent Chemotherapy and Extended-Field Intensity-Modulated Pelvic Radiotherapy (EF-IMRT)?
771. Effects of Amifostine on Acute and Late Toxicity of Radiotherapy and Concurrent Chemotherapy for Local Advanced Non-Small Cell Lung Cancer
772. P1-205: Acute esophagitis correlated with irradiated volume in a Phase II Study of Accelerated High Dose Thoracic Radiation Therapy (TRT) with Concurrent Chemotherapy for Limited Small Cell Lung Cancer (LSCLC) (RTOG 0239)
773. [Untitled]
774. [Untitled]
775. [Untitled]
776. [Untitled]
777. Tracheobronchial Obstruction as a Result of Mediastinal Mass
778. Immunisation of cattle in Zimbabwe using Theileria parva (Boleni) without concurrent tetracycline therapy
779. Prognostic Significance of FDG PET for Head and Neck Cancer Treated with IMRT
780. Stage IIIA Non-Small Cell Lung Cancers Treated with Neoadjuvant Concurrent Chemotherapy and High Dose Radiotherapy Followed by Resection
781. Re-irradiation of Recurrent Head and Neck Cancers with IMRT Technique and Concurrent Chemotherapy
782. Promise and challenges of peptide-poly: ICLC vaccines for adult and pediatric gliomas
783. Triweekly Carboplatin Alone as Concurrent Chemotherapy for Oropharyngeal Carcinoma Treated With Definitive Chemoradiation: Outcomes of 120 Unselected Patients and a Comparison to the RTOG 0129 Regimen Results
784. A Phase 2 Trial of Midtreatment FDG-PET Adaptive, Individualized Radiation Therapy Plus Concurrent Chemotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)
785. Dose-Escalated Hypofractionated Intensity Modified Radiation Therapy (IMRT) With Concurrent Chemotherapy for Inoperable or Unresectable Non-Small Cell Lung Cancer (NSCLC)
786. Postoperative Radiation Therapy for Salivary Gland Malignancies: Risk Stratification for the Impact of Concurrent Chemotherapy
787. Duration of Thoracic Radiation Therapy With Concurrent Chemotherapy Is Important for the Outcome of Patients With Limited-Stage Small Cell Lung Cancer (L-SCLC)
788. A Prospective Study With Concurrent Chemotherapy and Thoracic 3-Dimensional Radiation Therapy for Stage IV Non-Small Cell Lung Cancer: The Impact of Response on Survival
789. Hyperfractionated radiotherapy and cetuximab with concurrent chemotherapy in locally advanced stage IV head and neck carcinomas
790. SU-E-J-197: Tracking Tumor Response Over Treatment Course in IMRT and Proton Patients
791. A phase II trial of mid-treatment FDG-PET adaptive, individualized radiation therapy plus concurrent chemotherapy in patients with non-small cell lung cancer (NSCLC)
792. Preliminary clinical outcomes and dosimetry study on adaptive IMRT integrated HDR brachytherapy in local advanced uterine cervical cancer
793. 60P A RANDOMIZED TRIAL COMPARING CONVENTIONAL FRACTIONATION VERSUS ACCELERATED HYPERFRACTIONATION WITH THREE DIMENSIONAL CONFORMAL RADIOTHERAPY (3D-CRT) AND CONCURRENT CHEMOTHERAPY IN UNRESECTABLE NON SMALL CELL LUNG CANCER
794. Relationship between volume of bone irradiated during pelvic radiation therapy (RT) for rectal cancer and complete blood counts (CBC)
795. Course of calcium and magnesium serum levels in cetuximab-treated patients: Relation to concurrent chemotherapy and possible predictive value
796. Anal cancer: current and future treatment strategies
797. Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three or more minor risk factors: a propensity score matching analysis.
798. Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.
799. A single institute retrospective trial of concurrent chemotherapy with SIR-Spheres ® versus SIR-Spheres ® alone in chemotherapy-resistant colorectal cancer liver metastases.
800. Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.